MedTech Acquisition Corporation

Status: Deal Closed

U=S+W/3 W=S@11.5

IPO Proceeds, $M	$250.00M
IPO Date	Dec 18, 2020
CEO	Christopher C. Dewey
Left Lead	Raymond James
IPO Cash in Trust	100.0%
SPAC Tenor	24 + 6 + 3
IPO Sector	Healthcare Healthcare in the United States
IPO Geography	US/Canada
Target Company	TriSalus Life Sciences
Deal Announced	Nov 14, 2022
Deal Size, $M	$238.40M
Deal Sector	Healthcare
Deal Geography	US/Canada
SEC Filings	www.sec.gov
Approval Vote	Aug 8, 2023
Amendment Vote	Jun 12, 2023
Closing Date	Aug 10, 2023

Formerly MTAC TLSI TLSIW

Price	$4.07
Last closing price	$4.12
H/L, today	$3.90 / $4.30
H/L, 52-week	$4.11 / $16.24
Volume, today	14,199
Volume, 3-month avg.	N/A

Price
Volume, today
Volume, 3-month avg.	N/A

Price	$1.31
Last closing price	$1.32
High/low price, today	$1.30 / $1.42
High/low price, 52-week	$0.09 / $0.48
Volume, today	1,868
Volume, 3-month avg.	N/A

Price
Volume, today
Volume, 3-month avg.	N/A

No credit card required

Structure and cap table
9 directors & officers
53 filings and events
1 underwriters
2 deal advisors
2 legal advisors

Structure

Sign in to view structure, cap table, and calendar of events.

Team

Name	Age	Title
Karim Karti	52	Chairman
Christopher C. Dewey	76	CEO and Director
David J. Matlin	59	CFO and Director
Robert H. Weiss	62	CAO and Secretary
Martin Roche, MD	54	Director
Thierry Thaure		Director
Manuel “Manny” Aguero		Director
David L. Treadwell		Director
Michael Stansky		Special Advisor

Sign in to view team biographies and more sponsor and affiliate data.

Advisors

Underwriters

Raymond James	BR	22,000,000	units
		22,000,000	units
Up-Front UW fee		2.00	%
Deferred UW fee		3.50	%

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings


Nov 30, 2020	Initial S-1
Dec 9, 2020	S-1/A Amendment #1 Sign In to view filing content.
Dec 17, 2020	PR announcing pricing of upsized $220mm IPO Sign In to view filing content.
Dec 21, 2020	424B4 IPO Prospectus
Dec 23, 2020	8-K announcing partial over-allotment exercise Sign In to view filing content.
Feb 5, 2021	8-K announcing separate trading of common stock and warrants Sign In to view filing content.
Mar 22, 2021	8-K announcing change in directors Sign In to view filing content.
May 3, 2021	8-K announcing change in directors Sign In to view filing content.
May 19, 2021	Rumor of negotiations with Memic Sign In to view filing content.
Aug 13, 2021	8-K announcing business combination with Memic Sign In to view filing content.
Sep 30, 2021	F-4 Registration statement containing preliminary proxy for Memic approval meeting Sign In to view filing content.
Dec 22, 2021	F-4/A Amendment #1 to registration statement containing preliminary proxy for Memic business combination Sign In to view filing content.
Jan 14, 2022	F-4/A Amendment #2 to registration statement containing preliminary proxy for Memic business combination Sign In to view filing content.
Feb 8, 2022	F-4/A Amendment #3 to registration statement containing preliminary proxy for Memic business combination
Feb 10, 2022	F-4/A Amendment #4 to registration statement containing preliminary proxy for Memic business combination
Feb 14, 2022	424B3 Definitive proxy/prospectus for Memic transaction Sign In to view filing content.
Feb 23, 2022	8-K announcing change in directors Sign In to view filing content.
Mar 8, 2022	8-K announcing change in Directors Sign In to view filing content.
Mar 10, 2022	8-K announcing termination of Memic business combination Sign In to view filing content.
Oct 24, 2022	PRE14A Preliminary proxy for charter extension meeting Sign In to view filing content.
Nov 7, 2022	DEF14A Definitive Proxy for charter extension meeting Sign In to view filing content.
Nov 14, 2022	8-K announcing business combination with TriSalus Life Sciences Sign In to view filing content.
Nov 28, 2022	DEFA14A amendment to definitive proxy for charter extension meeting Sign In to view filing content.
Dec 8, 2022	8-K announcing adjournment of charter extension meeting Sign In to view filing content.
Dec 19, 2022	8-K with extension meeting results Sign In to view filing content.
Jan 6, 2023	S-4 registration statement containing preliminary proxy for TriSalus Life Sciences business combination Sign In to view filing content.
Feb 14, 2023	S-4/A Amendment #1 to registration statement containing preliminary proxy for TriSalus Life Sciences business combination Sign In to view filing content.
Feb 16, 2023	8-K with updated investor presentation Sign In to view filing content.
Feb 21, 2023	8-K with update to TriSalus Life Sciences management Sign In to view filing content.
Mar 8, 2023	8-K with amendment to TriSalus Life Sciences merger agreement Sign In to view filing content.
Apr 5, 2023	8-K with amendment to TriSalus Life Sciences merger agreement Sign In to view filing content.
Apr 20, 2023	8-K with update on intended merger target - TriSalus Life Sciences Sign In to view filing content.
Apr 21, 2023	S-4/A Amendment #2 to registration statement containing preliminary proxy for TriSalus Life Sciences business combination Sign In to view filing content.
May 9, 2023	PRE14A Preliminary Proxy for charter extension meeting Sign In to view filing content.
May 15, 2023	8-K with amendment to TriSalus Life Sciences merger agreement Sign In to view filing content.
May 23, 2023	S-4/A Amendment #3 to registration statement containing preliminary proxy for TriSalus Life Sciences business combination Sign In to view filing content.
May 24, 2023	DEF14A Definitive Proxy for charter extension meeting Sign In to view filing content.
Jun 8, 2023	8-K announcing $17.9mm convertible note investment and backstop agreement Sign In to view filing content.
Jun 8, 2023	S-4/A Amendment #4 to registration statement containing preliminary proxy for TriSalus Life Sciences business combination Sign In to view filing content.
Jun 15, 2023	8-K with extension meeting results Sign In to view filing content.
Jun 22, 2023	Form D notice of exempt offering of securities
Jun 30, 2023	8-K announcing conversion of Class B shares Sign In to view filing content.
Jul 6, 2023	8-K announcing additional financing Sign In to view filing content.
Jul 6, 2023	S-4/A Amendment #5 to registration statement containing preliminary proxy for TriSalus Life Sciences business combination Sign In to view filing content.
Jul 11, 2023	S-4/A Amendment #6 to registration statement containing preliminary proxy for TriSalus Life Sciences business combination
Jul 14, 2023	S-4/A Amendment #7 to registration statement containing preliminary proxy for TriSalus Life Sciences business combination
Jul 18, 2023	424B3 Definitive proxy for TriSalus Life Sciences business combination Sign In to view filing content.
Aug 2, 2023	8-K announcing postponement of TriSalus Life Sciences approval meeting Sign In to view filing content.
Aug 9, 2023	8-K with TriSalus Life Sciences meeting results Sign In to view filing content.
Aug 10, 2023	CA Corporate Action Alert announcing closing of TriSalus Life Sciences business combination Sign In to view filing content.
Aug 16, 2023	Super 8-K for closing of TriSalus Life Sciences business combination Sign In to view filing content.
Dec 15, 2023	S-1 Post-closing registration statement Sign In to view filing content.
Dec 26, 2023	EFFECT Effectiveness of post-closing registration statement Sign In to view filing content.

Shareholders

Sign in to view shareholders 13F filing data.